NCT03798015

Brief Summary

Reconstructive mitral valve surgery is increasingly done by minimal- invasive anterolateral thoracotomy technique in contrast to surgical approach by sternotomy. The minimal invasive approach is favourable regarding surgical trauma, length of hospital stay and amount of blood loss. This study is to investigate the neurological outcome after minimal- invasive mitral valve surgery compared to open mitral valve surgery by sternotomy. Pre-, intra- and postsurgical data from mitral valve surgery derived from the Basel mitral valve registry (collected from 2009 until now) will be analyzed.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Feb 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2009

Completed
9.9 years until next milestone

First Submitted

Initial submission to the registry

January 7, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 9, 2019

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

April 20, 2022

Status Verified

April 1, 2022

Enrollment Period

12.8 years

First QC Date

January 7, 2019

Last Update Submit

April 12, 2022

Conditions

Keywords

mitral valve surgerymitral valve stenosismitral valve insufficiencyminimal invasive mitral valve surgeryneurological outcome

Outcome Measures

Primary Outcomes (1)

  • occurence of stroke (yes/ no) subsequent to mitral valve surgery

    assessment of ischemic or hemorrhagic stroke subsequent to mitral valve surgery

    post surgical from day of surgery until day of discharge from hospital (approx. 2 weeks)

Study Arms (1)

mitral valve surgery

outcome of mitral valve surgery (stroke yes or no)

Other: mitral valve surgery

Interventions

assessment of ischemic or hemorrhagic stroke subsequent to mitral valve surgery

mitral valve surgery

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients undergoing a surgical mitral valve reconstruction or replacement at the University Hospital Basel from 2009 until today

You may qualify if:

  • surgery for mitral valve (reconstruction or replacement) (maybe combined with surgery for tricuspid valve and/ or surgery for atrial septal defects and/or patent foramen ovale)

You may not qualify if:

  • pre- existing neurological deficit; neurologic limitation in daily life
  • emergency surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Herzchirurgie University Hospital Basel

Basel, 4031, Switzerland

Location

MeSH Terms

Conditions

Mitral Valve StenosisMitral Valve Insufficiency

Condition Hierarchy (Ancestors)

Heart Valve DiseasesHeart DiseasesCardiovascular Diseases

Study Officials

  • Martin Grapow, Prof. Dr. MD

    Klinik für Herzchirurgie, Universitätsspital Basel

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 7, 2019

First Posted

January 9, 2019

Study Start

February 1, 2009

Primary Completion

December 1, 2021

Study Completion

December 1, 2021

Last Updated

April 20, 2022

Record last verified: 2022-04

Locations